Véronique FREUND-MICHEL

Has grant

Professor of Pharmacology

University of Bordeaux

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Right heart failure consecutive to pulmonary hypertension in women: identification of new therapeutic targets

Open Date: 2021-01-01

Close Date: 2023-01-01

Grant: Close

Pathophysiological mechanisms activated by the nerve growth factor NGF in pulmonary hypertension

Open Date: 2018-01-01

Close Date: 2021-01-01

Grant: Close

Pathophysiological mechanisms activated by NGF in pulmonary arterial remodelling associated to pulmonary hypertension: role of Connexin-43

Open Date: 2018-01-01

Close Date: 2019-01-01

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

FRANCE

View details

Thomas Ducret

University of Bordeaux

FRANCE

View details

Guillaume Cardouat

University of Bordeaux

FRANCE

View details

Laurent CRONIER

Assistant professor

University of Poitiers

FRANCE

View details

RAFFAELLA SOLETI

FRANCE

View details

Roger Marthan

Professor

University of Bordeaux

FRANCE

View details

Tatiana Victoni

Professeur Assistant

VetAgro Sup

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Véronique FREUND-MICHEL

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (14)

Effects of the nerve growth factor and its carrier protein on the inflammatory response from human monocytes

NGF increases Connexin-43 expression and function in pulmonary arterial smooth muscle cells to induce pulmonary artery hyperreactivity.

[Nerve growth factor (NGF) in pulmonary hypertension (PH)]

OP2113, a new drug for chronic hypoxia-induced pulmonary hypertension treatment in rat.

Inflammation and Oxidative Stress Induce NGF Secretion by Pulmonary Arterial Cells through a TGF-β1-Dependent Mechanism

Cell Confluence Modulates TRPV4 Channel Activity in Response to Hypoxia

NiONP-Induced Oxidative Stress and Mitochondrial Impairment in an In Vitro Pulmonary Vascular Cell Model Mimicking Endothelial Dysfunction

NiONPs-induced alteration in calcium signaling and mitochondrial function in pulmonary artery endothelial cells involves oxidative stress and TRPV4 channels disruption

Piezo1 Channel Activation Reverses Pulmonary Artery Vasoconstriction in an Early Rat Model of Pulmonary Hypertension: The Role of Ca<sup>2+</sup> Influx and Akt-eNOS Pathway.

[Involvement of the Piezo1 and TRPV4 stretch-activated channels in pulmonary hypertension].

Mechanosensitivity in Pulmonary Circulation: Pathophysiological Relevance of Stretch-Activated Channels in Pulmonary Hypertension

Effects of FW2 Nanoparticles Toxicity in a New In Vitro Pulmonary Vascular Cells Model Mimicking Endothelial Dysfunction.

Connexin-43 is a promising target for pulmonary hypertension due to hypoxaemic lung disease.

[The expression and role of nerve growth factor (NGF) in pulmonary hypertension].

Collaborators (11)

Pauline Esteves

Thais Porto Ribeiro

jean-francois Quignard

Magalie Baudrimont

Marilyne Campagnac

Thomas Ducret

Guillaume Cardouat

Laurent CRONIER

RAFFAELLA SOLETI

Roger Marthan

Tatiana Victoni

Make your next move.